Llwytho...
Reducing the use of inhaled corticosteroids in mild-moderate COPD: an observational study in east London
Inhaled corticosteroids (ICS) are often prescribed for worsening breathlessness, exacerbation frequency or lung function in chronic obstructive pulmonary disease (COPD). In mild-moderate disease and infrequent exacerbations, treatment risks may outweigh benefits and ICS may be withdrawn safely under...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | NPJ Prim Care Respir Med |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Nature Publishing Group UK
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395712/ https://ncbi.nlm.nih.gov/pubmed/32737296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41533-020-00191-y |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|